key: cord-0935343-5612ru9d
authors: Nasso, Giuseppe; Santarpino, Giuseppe
title: SARS‐CoV‐2 myocarditis in pediatric patients: We are ready to do whatever it takes to save them!
date: 2022-02-13
journal: J Card Surg
DOI: 10.1111/jocs.16321
sha: 6855379e66ec79a9cb253ea12abf3167f3f86fe4
doc_id: 935343
cord_uid: 5612ru9d

nan

First of all, the knowledge of this possible occurrence is crucial:

although myocarditis from SARS-CoV-2 infection is quite rare (<2%), its prevalence suggests that the absolute number of patients who develop this complication is indeed globally high.

Appropriate planning of ECMO implantation is extremely important for the choice of the materials necessary for extracorporeal support (e.g., cannula size depends on the child's weight) and also for the skills required (anesthesiologist, pediatrician, cardiologist, pediatric cardiac surgeon, pediatric perfusionist, etc.).

Although further data are needed to confirm the favorable outcome reported by Buitrago et al., we hope this ECMO approach in pediatric patients will achieve better results than those recorded in the adult population, managing to save these patients using venoarterial ECMO rather than venovenous ECMO supporting exclusively lung function and used as a rescue strategy for severe respiratory failure due to SARS-CoV-2 infection.

http://orcid.org/0000-0002-3519-770X

A case of fulminant myocarditis due to COVID-19 in an adolescent patient successfully treated with venous arterial ECMO as a bridge to recovery